Medicine Description irbevasc-plus 300/12.5 mg
irbevasc Plus 300/12.5 mg tablets is a medication combining irbesartan, an angiotensin II receptor blocker, and hydrochlorothiazide, a thiazide diuretic. Irbesartan selectively inhibits the binding of angiotensin II to its receptors, leading to vasodilation, decreased secretion of aldosterone, and reduced blood pressure. Hydrochlorothiazide promotes renal excretion of sodium and water by inhibiting sodium reabsorption in the distal convoluted tubule, which decreases blood volume and ultimately contributes to lower blood pressure. Together, these actions result in effective management of hypertension and alleviation of fluid retention.
Indications and Uses of irbevasc Plus 300/12.5 mg tablets
- Management of essential hypertension
- Reduction of fluid retention in certain patients
Side Effects of irbevasc Plus 300/12.5 mg tablets
- Dizziness
- Fatigue
- Hypotension
- Electrolyte imbalances
- Increased urination
Storage and Handling
Store irbevasc Plus tablets in a cool, dry place away from direct sunlight. Keep the medication out of reach of children and do not use it beyond the expiration date indicated on the packaging.
Patient Advice and Precautions
Patients should be advised to monitor their blood pressure regularly. It is important to maintain hydration and report any unusual symptoms such as severe dizziness or swelling to a healthcare provider. Avoid abrupt discontinuation of the medication without consulting a healthcare professional, as this may lead to a rebound increase in blood pressure.